Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

Benzer Materyaller

• Sirolimus, tacrolimus and low-dose methotrexate as graft versus host disease prophylaxis in related and unrelated donor reduced intensity conditioning allogeneic peripheral blood stem cell transplantation
  Yazar:: Alyea, Edwin P., ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/Mtx) as Acute GVHD Prophylaxis after Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
  Yazar:: Ho, Vincent T., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
  Yazar:: Koreth, John, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
  Yazar:: Cutler, Corey, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Effect of sirolimus on immune reconstitution following myeloablative allogeneic stemcell transplantation: An ancillary analysis of a randomized controlled trial comparing Tacrolimus/Sirolimus with Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)
  Yazar:: Gooptu, Mahasweta, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)